Research Grant

[Cite as]

Researchers: A/Pr Kelli Macdonald (Principal investigator)

Brief description Hematopoietic stem cell transplantation (SCT) is the only curative therapy for most blood cancers. The curative property of SCT relates to the graft-versus-leukaemia effect, which eradicates any remaining cancer after SCT. Unfortunately the success of SCT is significantly limited by three procedural complications: GVHD, graft failure, and infection. Our research aims to improve our understanding how these complications arise to develop new therapies that can be translated to clinical practice.

Funding Amount $AUD 956,055.65

Funding Scheme Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]